Alternatives to BridgeBio Pharma

BridgeBio Pharma is a Biotech tool: biopharmaceutical company developing transformative medicines for patients with genetic diseases and cancers. Here are the 54 closest alternatives, compared on pricing, features and what real users say.

BridgeBio Pharma profile More Biotech alternatives

The 20 closest Biotech companies to BridgeBio Pharma

Travere Therapeutics
Not rated
A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
Alector
Not rated
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Visit site
ANI Pharmaceuticals
Not rated
Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Visit site
Braeburn
Not rated
Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
Visit site
NRG Therapeutics
Not rated
A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
Visit site
Amgen
3.0 out of 5 (1)
A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Visit site
EyeGate Pharmaceuticals
Not rated
Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
Visit site
Denali Therapeutics
Not rated
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Visit site
Cradle
3.0 out of 5 (1)
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
BenchSci
2.0 out of 5 (2)
AI-powered platform for understanding disease biology and accelerating drug discovery.
Visit site
Manifold Bio
Not rated
AI-guided drug discovery platform for tissue-targeted medicines.
Visit site
Synthace
Not rated
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Visit site
Cue Biopharma, .
Not rated
Developing engineered biologics to harness the immune system for disease treatment.
Visit site
Arzeda
Not rated
Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.
Visit site
Lexeo Therapeutics
3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
LabGenius Therapeutics
Not rated
AI-driven drug discovery platform for rapid development of novel therapeutics.
Visit site
Iambic Therapeutics
3.0 out of 5 (1)
AI-driven drug discovery company developing novel medicines for unmet patient needs.
Visit site
Deep Genomics
Not rated
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Visit site

Company	Rating	Visit
Travere TherapeuticsA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
AlectorBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.	Not rated	Visit site
ANI PharmaceuticalsDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.	Not rated	Visit site
BraeburnDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.	Not rated	Visit site
NRG TherapeuticsA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.	Not rated	Visit site
AmgenA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.	3.0 out of 5 (1)	Visit site
EyeGate PharmaceuticalsClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.	Not rated	Visit site
Denali TherapeuticsBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.	Not rated	Visit site
CradleCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base	3.0 out of 5 (1)	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
BenchSciAI-powered platform for understanding disease biology and accelerating drug discovery.	2.0 out of 5 (2)	Visit site
Manifold BioAI-guided drug discovery platform for tissue-targeted medicines.	Not rated	Visit site
SynthaceSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.	Not rated	Visit site
Cue Biopharma, .Developing engineered biologics to harness the immune system for disease treatment.	Not rated	Visit site
ArzedaComputational protein design company creating novel enzymes and proteins using AI and physics-based modeling.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	3.0 out of 5 (1)	Visit site
LabGenius TherapeuticsAI-driven drug discovery platform for rapid development of novel therapeutics.	Not rated	Visit site
Iambic TherapeuticsAI-driven drug discovery company developing novel medicines for unmet patient needs.	3.0 out of 5 (1)	Visit site
Deep GenomicsAI-powered biotechnology company developing RNA therapeutics for genetic diseases.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the BridgeBio Pharma profile.

Sponsored rows are paid and labelled. Advertise on this page